Roy D. Baynes, Director: Travere Therapeutics TVTX Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $320,000
Shares · price: 16,000 sh · $20.00 a share
Held after: 31,000 sh
Stock: Travere Therapeutics TVTX
Person: Roy D. BaynesDirector
Trade date: 25/01/23
Filed: 25/01/23
Days to filing: 0 days

Sold 34.0% of holdings

Share of holding sold: 34.0%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/24~25/02/22

Roy D. Baynes's recent trades

Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/16
Traded 06/12
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/12
Traded 06/12
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/06
Traded 05/05
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/05
Traded 05/05
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$431.1K
9,750 sh
$431.1K
Filed 05/04
Traded 05/01